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STUDY QUESTION: Is endometriosis associated with abnormally located endometrial basalis-like (SSEA1+/SOX9+) cells in the secretory
phase functionalis and could they contribute to ectopic endometriotic lesion formation?
SUMMARY ANSWER:Women with endometriosis had an abnormally higher number of basalis-like SSEA1+/SOX9+ epithelial cells pre-
sent in the stratum functionalis and, since these cells formed 3D structures in vitro with phenotypic similarities to ectopic endometriotic lesions,
they may generate ectopic lesions following retrograde menstruation.
WHAT IS KNOWN ALREADY: Endometrial basalis cells with progenitor potential are postulated to play a role in the pathogenesis of
endometriosis and SSEA1 and nuclear SOX9 (nSOX9) mark basalis epithelial cells that also have some adenogenic properties in vitro.
Induction of ectopic endometriotic lesions in a baboon model of endometriosis produces characteristic changes in the eutopic endometrium.
Retrograde menstruation of endometrial basalis cells is proposed to play a role in the pathogenesis of endometriosis.
STUDY DESIGN, SIZE, DURATION: This prospective study included endometrial samples from 102 women with and without endo-
metriosis undergoing gynaecological surgery and from six baboons before and after induction of endometriosis, with in vitro assays examining
the differentiation potential of human basalis-like cells.
PARTICIPANTS/MATERIALS, SETTING, METHODS: The study was conducted at a University Research Institute. SSEA1 and SOX9
expression levels were examined in human endometrial samples from women aged 18–55 years (by immunohistochemistry (IHC) and qPCR) and from
baboons (IHC). The differential gene expression and differentiation potential was assessed in freshly isolated SSEA1+ endometrial epithelial cells from
women with and without endometriosis (n= 8/group) in vitro. In silico analysis of selected published microarray datasets identiﬁed differential regulation of
genes of interest for the mid-secretory phase endometrium of women with endometriosis relative to that of healthy women without endometriosis.
MAIN RESULTS AND THE ROLE OF CHANCE: Women with endometriosis demonstrated higher number of basalis-like cells
(SSEA1+, nSOX9+) in the functionalis layer of the eutopic endometrium compared with the healthy women without endometriosis in the
secretory phase of the cycle (P < 0.05). Induction of endometriosis resulted in a similar increase in basalis-like epithelial cells in the eutopic
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baboon endometrium. The isolated SSEA1+ epithelial cells from the eutopic endometrium of women with endometriosis had higher expres-
sion of OCT4, NANOG, FUT4 mRNA (P = 0.05, P = 0.007, P = 0.018, respectively) and they differentiated into ectopic endometriotic gland-
like structures in 3D culture, but not into mesodermal lineages (adipose or bone cells).
LARGE SCALE DATA: N/A
LIMITATIONS, REASONS FOR CAUTION: Small sample size. Bioinformatics analysis and results depends on the quality of published
microarray datasets and the stringency of patient selection criteria employed. Differentiation of SSEA-1+ cells was only examined for two
mesodermal lineages (adipogenic and osteogenic).
WIDER IMPLICATIONS OF THE FINDINGS: Since endometrial epithelial cells with SSEA1+/nSOX9+ basalis-like phenotype generate
endometriotic gland-like structures in vitro, they may potentially be a therapeutic target for endometriosis. An in depth analysis of the function
of basalis-like eutopic endometrial epithelial cells might provide insights into their potential deregulation in other disorders of the endomet-
rium including heavy menstrual bleeding and endometrial cancer where their function may be aberrant.
STUDY FUNDING/COMPETING INTEREST(S): We acknowledge the support by Wellbeing of Women project grant RG1073 (D.K.H.,
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Introduction
Endometriosis is a common gynaecological disease, deﬁned by the pres-
ence of benign endometrial epithelial and stromal cells outside of the
uterine cavity. The ectopic (extra-uterine) endometriotic lesions retain
features of eutopic (uterine) endometrial cells, such as oestrogen
dependency and thus undergo cyclical growth and regeneration, result-
ing in inﬂammation and scar/adhesion formation. While the pathogen-
esis of endometriosis is not fully understood (Sourial et al., 2014), the
most commonly accepted theory is retrograde menstruation. This
involves the trans-tubal migration and engraftment of viable endometrial
fragments to the peritoneal mesothelium, establishing ectopic endome-
triotic lesions (Sampson, 1927). The theory is limited in that retrograde
menstruation is a natural phenomenon, and has been demonstrated in
over 90% of women (Blumenkrantz et al., 1981), yet the prevalence of
endometriosis in the general premenopausal female population is esti-
mated only at 5–10% (Halme and Surrey, 1990). Such a discrepancy sug-
gests that the aetiology is more complex. Adult stem/progenitor cells
are believed to be responsible for the remarkable regenerative capacity
of human endometrium, and are thus also implicated in proliferative
endometrial pathologies, such as endometriosis (Gargett et al., 2008;
Valentijn et al., 2013; Sourial et al., 2014; Tempest et al., 2018).
Epithelial cells with progenitor function are postulated to be located
in the basalis layer of the premenopausal endometrium (Prianishnikov,
1978; Schwab et al., 2008; Valentijn et al., 2013; Tempest et al., 2018).
Leyendecker and colleagues further developed the theory of retro-
grade menstruation by proposing that women with endometriosis
shed a higher number of basalis-like cells together with their eutopic
endometrial functionalis, which then initiate ectopic endometriotic
deposits (Leyendecker et al., 2002). The group also hypothesised that
secretory phase functionalis endometrium from women with endomet-
riosis contain more ‘basalis-like cells’ and subsequently tried to charac-
terise such cells on the basis of steroid receptor expression. However,
since steroid receptors are expressed by cells located in both basalis
and functionalis layers of the normal endometrium, the theory remains
un-proven.
.............................................................................................................................................................................................
Table I Demographic data.
Endometriosis (n = 44) Healthy Control (n= 58) P-value (Mann–Whitney test)
Age (y) 38 (21–48) 41.5 (21–50) P < 0.01
BMI (kg/m2) 25.5 (17.1–40.6) 26.8 (18.9–52.2) n/s
Parity (%) P
0 22/44 (50%) 4/58 (7%)
1 9/44 (20%) 6/58 (10%)
2 9/44 (20%) 23/58 (40%)
>2 3/44 (7%) 24/58 (41%)
Unknown 1/44 (2%) 1/58 (2%)
Smokers 12/44 (27%) 15/58 (26%) n/s
Endometriosis stage 2 (1–4) n/a
Data expressed as median and range except smoking status and parity.
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We have previously shown that cells with an SSEA1/nSOX9+ signature
which are abundant in the basalis region of the eutopic endometrium, have
some in vitro progenitor activity and a similar epithelial cell phenotype is
observed in ectopic endometriotic lesions (Valentijn et al., 2013).
Furthermore, epithelial progenitor cell activity has been either demon-
strated or proposed in endometrial epithelial cells expressing N-cadherin
(Nguyen et al., 2017), Musashi-1 (Gotte et al., 2008; Tempest et al., 2018),
LGR5 (Tempest et al., 2018) and in a small proportion of side population
(SP) cells (Masuda et al., 2010; Cervello et al., 2011). Ectopic endometriotic
lesions also express Musashi-1 (Gotte et al., 2008; Tempest et al., 2018).
The baboon model of induced endometriosis simulates retrograde
menstruation by the intra-peritoneal inoculation of menstrual endomet-
rium curetted on menstrual Day 2 of the cycle, in two consecutive cycles.
The model has complete success at inducing endometriosis both macro-
and microscopically at 3 months (Harirchian et al., 2012), and has thus
facilitated understanding of the chronological changes in the disease pro-
cess showing subsequent alterations in both the eutopic and ectopic
endometrium after the establishment of initial ectopic endometriotic
lesions (Braundmeier and Fazleabas, 2009; Hapangama et al., 2010).
In this present study, we aimed to investigate the role that the previ-
ously characterised SSEA1+/nSOX9+ endometrial epithelial cells
(Valentijn et al., 2013) play in the pathogenesis of endometriosis by
addressing the following research questions:
• Do women with endometriosis have an abnormally high number of
SSEA1+/nSOX9+ basalis-like epithelial cells located in the secre-
tory phase functionalis layer of the eutopic endometrium compared
with healthy fertile women without endometriosis?
• Does induction of ectopic endometriotic lesions increase SSEA1+/
nSOX9+ epithelial cells in the eutopic endometrium in a baboon
model, simulating human disease?
• Are there differences in gene expression in SSEA1+ eutopic endo-
metrial epithelial cells from women with and without endometriosis?
• What is the differentiation potential of puriﬁed SSEA1+ endometrial
epithelial cells and can they produce gland-like structures similar to
ectopic endometriotic lesions in vitro?
Materials andMethods
Human tissue collection
Collection of human endometrium was approved by Liverpool Adult Ethics
committee (REC references; 09/H1005/55 and 11/H1005/4) and 89 human
endometrial samples from pre-menopausal women (who had not been on
hormonal treatments in the preceding 3 months) undergoing hysterectomy or
laparoscopy were collected. From hysterectomy specimens, a wedge of tissue
from the lumen to the muscular myometrial layer that included superﬁcial and
basal endometrium as well as myometrium was taken. A pipelle endometrial
sampler was used to sample the endometrial functionalis layer of women
undergoing laparoscopy. Further demographic information on patient
groups is included in Table I and Supplementary Table SI.
Induction of endometriosis in
the baboons
The previously described technique of intra-pelvic autologous inocula-
tion of curetted menstrual endometrium was employed to induce
endometriosis in six female baboons with regular menstrual cycles
(Fazleabas et al., 2002). All tissues (ectopic and eutopic) were
collected between Days 9–11 post-ovulation, which corresponds to
the window of implantation (WOI) in the baboon, after determining
the day of ovulation by serum E2 levels as previously described
(Fazleabas et al., 2002). This phase of the cycle where most known
features of endometriosis associated changes in the eutopic endomet-
rium is described was chosen for our study. Brieﬂy, prior to the induc-
tion of the disease, eutopic endometrium was obtained from ﬁve of
the six baboons. Following a 3 month rest period, laparoscopic autolo-
gous instillation of trans-cervically harvested menstrual endometrium
using a Unimar Pipelle (suction curette) (Day 2) into the pouch of
Douglas, the left and right cul-de-sac as well as the broad ligaments
near the fallopian tubes of the same baboon on two consecutive men-
strual cycles. Following the second inoculation, tissue was harvested
from the eutopic endometrium and ectopic lesions after 3 months
(n = 6) by performing laparoscopies and laparotomies as previously
described (Fazleabas et al., 2002) and one lesion per animal per time
point was analysed. Control endometrial tissues were also obtained at
a single time point from eight additional normally cycling baboons that
had not been inoculated with menstrual tissue. All animals weighed
between 12 and 18 kg, were aged 7–12 years, and included tissue
from previous studies (Fazleabas et al., 2002) and tissues that were
collected prospectively. The induction of the disease had no effect on
their menstrual cyclicity or peripheral ovarian steroid levels (Wang
et al., 2009). The Animal Care Committees of the University of Illinois,
Chicago and Michigan State University, approved all experimental pro-
cedures on baboons (Fazleabas et al., 2002)
Immunohistochemistry (IHC)
After collection, both human and baboon tissues were ﬁxed in 10%
(v/v) neutral buffered formalin for 24 h dehydrated through ethanol,
embedded in parafﬁn and 3 μm sections prepared for IHC. Standard
IHC was performed using heat induced antigen-retrieval and DAB
chromogen as previously described (Hapangama et al., 2010; Valentijn
et al., 2013). Immunostaining for all antibodies was analysed with spe-
ciﬁc reference to the two different epithelial compartments, the func-
tionalis (typically in a secretory phase sample, glands in the upper 2/3
of the endometrium below the luminal epithelium, surrounded by
sparse stroma) and the basalis (glands in the lower 1/3 of the endo-
metrium adjacent to the endo-myometrial junction, surrounded by
densely packed stroma) in full thickness hysterectomy endometrial tis-
sue sections. The SSEA1 and SOX9 expressing epithelial cells were
quantiﬁed using a modiﬁed Quickscore method which incorporates
both staining intensity (0 = negative, 1 = weak, 2 = moderate, 3 =
strong) and abundance (1 ≥ 0–25%, 2 ≥ 25–50%, 3 ≥ 50–75%, 4 ≥
75–100%). The intensity and percentage scores were then multiplied
and summed to give scores in the range 0–12 as previously described
(Schiessl et al., 2009; Valentijn et al., 2013; Mathew et al., 2016).
Antibodies used for IHC are detailed in Supplementary Table SII.
Cell sorting and analysis
Magnetic bead sorting (MACS) of single-cell epithelial suspensions
from endometrial samples were labelled with anti-SSEA1 (CD15)
MicroBeads (#130-094-530, Miltenyi Biotec, UK) and separated using
MACS separation columns (MS columns, Miltenyi Biotec, UK) accord-
ing to the manufacturer’s instructions and purity assessed as previously
reported (Valentijn et al., 2013).
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RNA extraction and cDNA synthesis
Total RNA from clinical tissue samples was extracted using TRIzol®
Plus RNA Puriﬁcation System (Life Technologies, Paisley, UK) accord-
ing to the manufacturer’s instructions. The quantity of total RNA was
determined by NanoDrop ND-1000 (ThermoFisher Scientiﬁc, UK).
Total RNA was reverse transcribed using AMV First Strand cDNA
synthesis kit (New England Bio Labs, Hertfordshire, UK). cDNA
was ampliﬁed by PCR using HotStart Taq (New England Bio Labs,
Hertfordshire, UK).
TRIzol® Reagent (Life Technologies) was used to isolate total RNA
which was precipitated from samples according to the manufacturer’s
instructions. Total RNA was extracted from whole tissue, SSEA1
sorted (MACS) cells and treated/untreated Ishikawa cells (positive
control) and reverse-transcribed into cDNA using the Superscript III
First-Strand Synthesis System (Invitrogen).
Quantitative real time polymerase chain
reaction (q-PCR) and RT-PCR
Semi-quantitative RT-PCR and qPCR were performed as previously
described (Hapangama et al., 2012; Valentijn et al., 2013) using KAPA
SYBR FAST qPCR Mix Master 2x (Kapa BioSystems) and the Rotor-
Gene 3000 centrifugal real-time cycler (Corbett Research). Relative
gene expression was calculated and normalised to the reference gene,
YWHAZ due to its stability in the endometrium (Vestergaard et al.,
2011). The ampliﬁcation products were veriﬁed using agarose gel elec-
trophoresis, stained with SYBR Safe (Life Technologies, Paisley, UK)
and visualised by UV transillumination using ChemiDoc-It TS2 Imager
(UVP systems, Cambridge, UK). The PCR primers (Sigma-Aldrich)
used are listed in Supplementary Table SIII.
3D epithelial cell cultures in Matrigel
Short-term cultured (16–36 h post-plating) MACS-bead sorted euto-
pic endometrial epithelial cells were trypsinised and re-suspended as
single cell suspensions at ~100 000 cells/200 μl in undiluted Matrigel
(BD Biosciences) and diluted with epithelial media serially two-fold to
~3000 cells/100 μl: 50 μl of the resulting mixture was plated in dupli-
cate in 24-well tissue culture plates. After allowing the Matrigel to set
at 37°C for 15–20 min, DMEM/F12 medium supplemented with
insulin-transferrin-selenite (ITS, Invitrogen) and 50 ng/ml EGF (Sigma-
Aldrich) was added. Medium was replaced every 3 days and cultures
monitored over 14 days.
For IHC and immunoﬂuorescence (IF), 3-D cultures were ﬁxed in
10% (v/v) neutral-buffered formalin (NBF) for 30 min, harvested
into 1% agarose in PBS and placed in NBF overnight at 4°C, then
processed to parafﬁn wax, 3 μm sections were cut and antigen-
retrieval performed (Supplementary Table SII). 3-D morphology
and polarity was assessed with antibodies to MUC-1, laminin, cyto-
keratin 18 and β-catenin (Supplementary Table SII) (Valentijn et al.,
2013).
Differentiation assay
Multi-lineage differentiation
Freshly harvested human eutopic endometrial epithelial cells were
MACS-bead-sorted into SSEA1+ and SSEA1– fractions before
placing in 2D culture in adipogenic and osteogenic media to assess
their adipogenic or osteogenic differentiation potential as described
below.
Adipogenic assay
Conﬂuent cells were stimulated with adipogenic media every 2–3 days
(High glucose DMEM/F12 (Lonza), 0.2% Primocin (Bioscience
LIfesciences), 500 μM IBMX (Sigma-Aldrich), 1 μM Dexamethaxone
(Sigma-Aldrich), 10 μM Insulin (Sigma Aldrich) (Gargett et al., 2009).
Non-stimulated cells were cultured in the same epithelial media as in
the 3D culture and served as a negative control. After 2 weeks, cells
were washed twice with PBS and ﬁxed by incubation with 4% para-
formaldehyde (PFA; Sigma-Aldrich) for 10 min, for analysis. Oil Red O
staining was used to conﬁrm the presence of lipid droplets. Brieﬂy, PBS
was removed from ﬁxed cells and replaced with 60% isopropanol
(Sigma-Aldrich). After 10 min, 60% Oil Red O stain solution was added
and left for another 10 min until washed with water. Cells were coun-
terstained with Gills 2 haematoxylin (Thermo Scientiﬁc). Images were
visualised and captured with the use of a Nikon Biophot Microscope
and camera head (Nikon).
Osteogenic assay
Near conﬂuent cells were stimulated every 2–3 days with osteogenic
medium for 2 weeks (High glucose DMEM/F12 (Lonza), 0.01 μM
Vitamin D3 (Sigma-Aldrich), 50μM L-ascorbic acid (Sigma-Aldrich),
10 mM β-glycerol phosphate (Sigma-Aldrich) (Gargett et al., 2009)).
Cells stimulated with epithelial medium for the same period served as a
negative control. On Day 15, cells were ﬁxed by incubation with 4%
PFA at room temperature for 10 min and subjected to Alkaline phos-
phatase (ALP) staining. Accordingly, PBS was aspirated from ﬁxed cells
and replaced with 400 μl of Fast Red/Napthol solution (Sigma-
Aldrich) and left to incubate at room temperature. After 30 min, cells
were rinsed with 0.1MTris HCl (pH 9.2) and PBS before counterstain-
ing with 4′,6-diamidino-2-phenylindole (DAPI).
hMSC cell culture
Human mesenchymal stem cells (hMSCs) were used as the positive
control for in vitro differentiation into adipocytes and osteocytes
(Lonza, Walkersville, Inc., USA). hMSC were cultured in Growth
MediumTM (hMSCGM; Lonza, Walkersville Inc., USA) and maintained
at 37°C, at 5% CO2 in air.
Systems biology
The differential expression of epithelial speciﬁc SOX9 and all fucosyl-
transferase (FUT) genes including FUT3 and FUT4, the enzymes which
catalyse the addition of the fucosyl moiety to the Lewis X molecule
that comprises the SSEA-1 epitope, as well as the differential expres-
sion of a total of 595 genes regulated by SOX9 in two gene sets (set
1 = 237 genes, set 2 = 358 genes from Illumina’s BaseSpace Correlation
Engine) in the secretory endometrium was examined in three published
whole transcriptomic RNA Expression studies examining the human
mid-secretory endometrium of women with endometriosis (1) moderate-
severe (n = 9, GSE6364 (Burney et al., 2007)), (2) mild (n = 9, GSE51981
(Tamaresis et al., 2014)), (3) moderate (n = 18, GSE51981 (Tamaresis
et al., 2014)) endometriosis suffers against healthy women without endo-
metriosis (GSE6364, n = 8; GSE51981, n = 8) using Illumina’s BaseSpace
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Correlation Engine (BSCE; (Kupershmidt et al., 2010) software;https://
www.illumina.com/informatics/research/biological-data-interpretation/
nextbio.html, last accessed on August 8, 2018; Illumina, San Diego, CA,
USA). We also interrogated gene lists (already published) in Supplementary
Table SII of Afshar et al., 2013) from microarray experiments comparing
secretory phase baboon eutopic endometrium from animals having either
spontaneous or induced endometriosis with healthy animals.
Statistical analysis
All statistical analyses were performed using GraphPad Prism software.
Summary statistics and paired t-test or non-parametric equivalent
(Mann–Whitney U and Spearman Rank) was employed as appropriate.
Data are presented as median and interquartile range as indicated.
Results were considered statistically signiﬁcant when P < 0.05.
Figure 1 Immunohistochemical staining for endometrial SSEA-1 and SOX9 in normal fertile women without endometriosis (n =
14) and women with surgically conﬁrmed symptomatic endometriosis (n = 10). Representative 400× micrographs showing the basalis and
functionalis staining (A). Scale bar is 50 μm. Graphs showing immunohistochemical staining quickscores for SSEA1 (B) and SOX9 (C) protein expres-
sion in endometrial functionalis of healthy control women and endometriosis patients in the secretory phase of the cycle. Charts display median and
quartiles with whiskers showing the range. Graphs depicting the enzymes likely responsible for catalysing the SSEA-1 epitope, FUT3 (D), FUT4 (E), and
SOX9 ( F) mRNA expression in healthy fertile control tissue (n = 3) and endometriosis patient samples (n = 6). Charts display median and quartiles
with whiskers showing the range but just median and range when n = 3.
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Results
Women with endometriosis show an
increased number of SSEA1 and nSOX9
expressing basalis-like cells located in the
functionalis layer of secretory phase eutopic
endometrium
We tested the hypothesis that women with endometriosis have an
increased number of basalis-like cells that will be shed in the subse-
quent menses. Signiﬁcantly increased epithelial quick-scores for SSEA1
and nSOX9 were observed in the functionalis layer of secretory phase
eutopic endometrium in women with endometriosis compared with
healthy fertile control women; (SSEA1 median = 0.85, IQR = 0.33–2.28,
versus median=0.01 IQR = 0–0.28, P = 0.02, (Fig. 1A and B)) and
nSOX9 (median=3.6, IQR = 1–7.4 versus median=0.60, IQR =
0.19–1.58, P = 0.04) (Fig. 1C).
The women with endometriosis also had higher basalis epithelial
quickscores in the secretory endometrium when compared with the
healthy fertile control women, for SSEA1 (median=5.00, IQR =
2.6–8.6 versus median=2.00, IQR = 1.6–2.6; P = 0.01) (Fig. 1B).
Although a similar trend was observed with nSOX9 it was not statistic-
ally signiﬁcant (median=22.5, IQR = 4.5–61.8 versus median=7.1,
IQR = 3.6–12; P = 0.3) (Fig. 1C).
To further understand the increased SSEA-1 immunostaining in
endometriosis tissues, we assessed several fucosyl transferase
enzymes (FUT3, FUT4) to determine if these differed. The FUTs enzy-
matically add the SSEA-1 epitope to Lewis X molecule. The transcript
for FUT3 and FUT4 used as a surrogate for SSEA1 epitope did not
change in the endometrial tissue derived from women with endometri-
osis (n = 6) compared with the healthy fertile control samples (n = 3)
(Fig 1D and E). In contrast, SOX9 mRNA levels were signiﬁcantly high-
er in tissue from women with endometriosis (median=1.2, IQR =
0.85–1.7, n = 6) compared with the healthy fertile control samples
(median 0.2, IQR = 0.2–1, n = 3, P < 0.05, Fig. 1F). In silico interroga-
tion of published curated datasets also revealed that several FUT genes
that could be responsible for the SSEA1 epitope (including FUT3, FUT4
as well as FUT2, FUT5, FUT6, FUT7) and SOX9 gene were up-regulated
(and 402/595 of SOX9 regulated genes were differentially regulated)
in mid-secretory phase endometria of women with endometriosis
compared with the samples of healthy women without endometriosis
(Supplementary Figure S1).
Both SOX9 and SSEA1 antigen expression were high in human
ectopic lesions (Supplementary Figure S2B, as previously shown in
Valentijn et al., 2013) suggesting a possible functional role for these in
the ectopic lesions.
Eutopic endometrial SSEA1 and SOX9
expression changed with the induction of
endometriosis in a baboon model
We hypothesised that the baboon model would allow examination of
chronological changes in basalis-like cells in ectopic and eutopic endo-
metrium after induction of endometriosis. Most epithelial cells of the
baboon ectopic endometriotic lesions had high nSOX9 immunostain-
ing conﬁrming similarities with the previously published human data
(Valentijn et al., 2013) (Fig. 2A). However, only two of four baboon
ectopic endometriotic lesions examined showed high SSEA1 expres-
sion (Fig. 2A, P > 0.05).
Three months after endometriosis induction, eutopic endometrial
functionalis also showed apparently higher but not signiﬁcant quick-
scores for nSOX9, at or above the median pre-inoculation scores in all
animals (Fig. 2B, P > 0.05). The control baboons showed similar endo-
metrial SOX9 expression pattern to the healthy humans with high
nSOX9 expression observed in the basalis glands (Fig. 2A).
Three months after induction of endometriosis, SSEA1 expression
increased in the eutopic endometrial basalis in 4/6 (67%) of the ani-
mals but unlike normal human basalis glands, only a very few discreet
SSEA1 expressing cells were observed in the eutopic endometrial
basalis of the control baboons (Fig. 2A). Speciﬁcally, by comparing the
previously published microarray data from eutopic endometrium from
baboons after induction of endometriosis with the pre-inoculation
endometrium of the same animals, we demonstrated increased
expression of SOX9 and many of the FUT genes (including FUT3,
FUT5, FUT8 and FUT11 that could be responsible for SSEA1 epitope
expression) in baboons.
Basalis-like (SSEA1+) epithelial cells of
women with endometriosis showed
differential gene expression compared with
the healthy women
Since endometriosis may result in retrograde ﬂow of the basalis-like
cells at menses, we next attempted to enrich for SSEA1+ basalis epi-
thelial cells derived from the eutopic endometrium of women with and
without endometriosis to assess their expression of a panel of selected
genes. Comparison of SSEA1+ sorted epithelial cells from women
with endometriosis and healthy fertile control women (n = 8/group),
showed a signiﬁcant up-regulation of two pluripotency genes NANOG
(P = 0.007) and OCT4 (P = 0.05), (Fig. 3D,E) although the abundance
of OCT4 was extremely low. The third gene required for pluripo-
tency, SOX2 was not expressed in whole healthy human endometrial
tissue or in any of the endometrial epithelial fractions (data not shown)
despite high expression in the positive control human embryonic stem
cells. Immunohistochemistry staining for anti-SOX2 in full thickness
endometrial samples revealed negative staining (Supplementary Fig.
S3), indicating that SSEA1+ cells are unlikely to be pluripotent and nei-
ther are pluripotent stem cells found in human endometrium. mRNA
for FUT4, was upregulated in SSEA1+ cells from women with endo-
metriosis compared with those from normal endometrium (Fig 3D).
There were no signiﬁcant differences in the endometrial differentiation
genes, PR or ESR1 between endometriosis and normal SSEA1+ sorted
cells (Fig. 3A,B). Neither was there any difference for the other epithe-
lial genes that have been proposed as progenitor markers in other tis-
sues assessed in our panel (PROM1, CD9 and PDXL, Fig. 3D, G,H).
SSEA1+ cells derived from the eutopic
endometrium of women with endometriosis
produce ectopic endometriotic lesion-like
structures in 3D culture
We then tested the hypothesis that SSEA1+ cells are able to generate
structures similar to ectopic endometriotic lesions in vitro. All sorted sam-
ples of SSEA1+ cells from eutopic endometrial cell suspensions of women
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with endometriosis generated gland-like structures within 14 days of 3D
culture. These 3D structures morphologically mimicked ectopic endo-
metrial epithelium (Fig. 4A and B). Co-localisation of the urogenital epi-
thelial marker cytokeratin-18 with the adherins junction molecule
β-catenin in ectopic lesions established their endometrial origin (Fig. 4A
and B) and epithelial phenotype of the ectopic cells. MUC1 at the apical
surface of the epithelia and basal laminin conﬁrmed the polarisation and
differentiation of the epithelial cells as well as their striking similarities with
Figure 2 Representative micrographs showing SSEA1 and SOX9 in the baboon model of endometriosis (A). Scale bar is 50 μm.
Graph shows functionalis glandular SOX9 quickscore and median values (B) for control (pre-inoculation) baboons (n = 5) and 3 months post-
inoculation (both eutopic endometrium (n = 6) and ectopic lesions (n = 5),). Mann–Whitney U test showed no statistically signiﬁcant difference in
SOX9 quickscore between control and 3 months post-inoculation for eutopic endometrium (P = 0.2) or ectopic lesions (P = 0.07) respectively.
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ectopic lesions (Fig. 4A and B). Immature gland-like structures (Fig. 4C)
consisted of cells expressing mainly ERβ with occasional cells expressing
ERα and the proliferative marker Ki67. However, the more mature larger
gland-like structures demonstrated nuclear staining in some cells for pro-
gesterone receptor but AR was not expressed by the epithelial cells in
3D culture at any stage (Fig. 4C and D).
SSEA1+ endometrial epithelial cells are
distinct frommesenchymal cells and do not
differentiate intomesodermal lineages in vitro
We then sought to conﬁrm that the SSEA1+ basalis-like cells are not
pluripotent and are likely to be unipotent, therefore if they reach the
Figure 3 Quantitative RT-PCR results from SSEA1+ sorted epithelial cells from women with endometriosis (n = 8) and control
women (n = 12) showing relative expression of ERα (ESR1, A), PGR (B), CD9 (C), FUT4 (D, Mann–Whitney U test P = 0.018), OCT4
(E, Mann–Whitney U test P = 0.05), NANOG ( F, Mann–Whitney U test P = 0.007), PROM1 (G) and PODXL (H). All data is shown rela-
tive to the housekeeping gene YWHAZ.
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peritoneal cavity will probably produce an endometrial epithelial
phenotype without differentiating into other mesenchymal cell types.
To this end, we ﬁnally assessed whether MACS sorted-SSEA1+
basalis-like epithelial cells derived from the eutopic endometrium of
women with endometriosis could differentiate into two representative
mesodermal lineages. Human bone marrow-derived mesenchymal
stem/stromal (hMSCs), which differentiate into adipocytes and osteo-
blasts served as a positive control. After 2 weeks in culture in appro-
priate induction media, hMSCs differentiated into adipocytes and
osteocytes (Fig. 5Ab and Cb). In contrast, SSEA1+ cells showed no
change in morphology and did not develop intracytoplasmic lipid dro-
plets after two weeks of culture in adipogenic medium (Fig. 5Ac), nor
did they show alkaline phosphatase activity after incubation in osteo-
genic medium (Fig. 5Cc). This was conﬁrmed by negative staining with
Oil Red-O and minimal expression, of early adipogenic markers
PPARγ2 and LPL (Fig. 5B). Similarly, mRNA expression of early osteo-
cyte differentiation markers (alkaline phosphatase, osterix) did not
change in SSEA1+ endometrial epithelial cells (Fig. 5D).
Discussion
This study examines the involvement of SSEA1+SOX9+ basalis-like
epithelial cells derived from eutopic endometrium in the pathogenesis
of endometriosis. We have shown that the eutopic endometrial func-
tionalis epithelium of women with endometriosis, aberrantly contain an
increased number of cells with SSEA1+SOX9+ basalis-like epithelial
cell phenotype. The chronological changes occurring in the eutopic
endometrium with induction of ectopic endometriotic lesions were
examined in the baboon, where induction of endometriosis resulted in
a trend to increased SOX9+ cells in eutopic endometrium. As previ-
ously described in human lesions, the baboon endometriotic lesions
induced in ectopic sites also contained SSEA1+SOX9+ cells. SSEA1
enriched cells derived from the eutopic endometrium of women with
endometriosis showed an increased level of expression of some
‘primitive’ genes compared with healthy women without endometri-
osis. These cells also produced 3D structures in vitro with phenotypic
similarities to ectopic endometriosis lesions collected from women,
Figure 4 Formalin-ﬁxed and parafﬁn-embedded sections of gland-like structures grown in 3D culture and ectopic lesions stained
by immunoﬂuoresence, for cytokeratin18/laminin (A), MUC-1/β-catenin (B). and for steroid receptors with immunohistochemistry show
ERβ was the dominant receptor in both early immature non-polarised (C) and mature, polarised (D) gland-like structures. Whilst both these structures
contained some cells expressing ERα and the proliferative marker Ki67, PR was only seen in the mature polarised structures. AR was not expressed by
any epithelial cells grown in 3D. Scale bar = 50 μm.
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Figure 5 Micrographs of staining and mRNA expression data depicting that SSEA1+ endometrial epithelial cells do not express
markers of mesodermal differentiation when cultured in adipogenic and osteogenic media. (A) Micrographs showing Oil O red staining
for d14/15 hMSC in control medium (a), hMSC in adipogenic medium (b) SSEA1+ epithelial cells in adipogenic medium (c). Relative expression com-
pared to control values were signiﬁcantly higher in hMSC for PPARg2 and LPL and unchanged in SSEA1+ sorted cells (B). (C) shows micrographs for
alkaline phosphatase staining in d14/15 hMSC in control medium (a), hMSC in osteogenic medium (b) SSEA1+ epithelial cells in osteogenic medium
(c) relative expression compared to control values were signiﬁcantly higher in hMSC for the osteogenic markers alkaline phosphatase (ALP) and osterix
(OSX), remaining unchanged in SSEA1+ sorted cells (D)
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suggesting that if they were deposited in the peritoneal environment
(ectopic locations) after retrograde menstruation, they may initiate
endometriotic lesions. SSEA-1+ cells derived from eutopic endomet-
rium were unable to differentiate into the mesodermal lineages (bone
and adipose), in vitro (Fig. 6).
Endometriosis is a disease associated with changes to eutopic endo-
metrium that are most prominent in the progesterone dominant
secretory phase of the cycle (Bulun et al., 2006). The baboon model of
endometriosis induction has demonstrated that establishment of
endometriosis in ectopic sites induces aberrant expression of many
genes and proteins that are characteristic of the eutopic endometrium
in women with endometriosis and may contribute to functional conse-
quences such as subfertility (Hastings and Fazleabas, 2006; Hapangama
et al., 2010; Sourial et al., 2014; Afshar et al., 2013). Interestingly,
SOX9 and some FUTs as well as MSI1 (Musashi-1) were amongst these
differentially expressed genes in baboons and these changes may be
relevant to aberrations in the number and location of basalis-like epi-
thelial cells and/or the increase in the progenitor cell activation/
migration.
These changes in the eutopic endometrium may also promote the
propagation of the disease (Hapangama et al., 2010; Tempest et al.,
2018). Leyendecker et al., proposed that women with endometriosis
shed endometrial tissue with a basalis-like phenotype at menstruation
(Leyendecker et al., 2002), and therefore these cells are more likely to
initiate ectopic lesions after retrograde menstruation. The recent dis-
covery that SOX9 and SSEA1 are preferentially expressed in basalis
epithelial cells (Valentijn et al., 2013) provided us with a means to test
Leyendecker’s theory and we have conﬁrmed that women with endo-
metriosis have an increased number of basalis-like cells in the secretory
functionalis layer that will subsequently be shed at menstruation. The
ﬁnding of numerous SSEA1+ cells in the functionalis of eutopic endo-
metrium of women with endometriosis also suggests their delayed dif-
ferentiation into SSEA1- functionalis epithelial cells given the recent
descriptions of a potential hierarchy of epithelial cells from the basalis
through the functionalis (Valentijn et al., 2013; Nguyen et al., 2017;
Tempest et al., 2018; Tempest et al., 2018). This ﬁnding also agrees
with the observation that the number of basalis-like cells increased in
the endometrium of the baboons after inducing endometriosis.
Interestingly, in the baboon model, an endometrial sampler was used
to collect the exposed progenitor rich endometrial basalis on the
second day of menstrual bleeding, and the subsequent placement of
this tissue in the pelvic cavity resulted in 100% induction of endometri-
osis (Braundmeier and Fazleabas, 2009). This well-established method
of endometriosis induction in the baboons conﬁrms the involvement
of basalis-like cells in the initial and subsequent ectopic endometriotic
lesion formation and Leyendecker’s theory that basalis-like cells give
rise to ectopic lesions. Furthermore, the previously published micro-
array data demonstrate, aberrant expression of these genes was per-
sistently observed during disease progression after induction of
endometriosis in baboons (already published in Supplementary Table
SII of Afshar et al., 2013).
FUT enzymes catalyse the addition of fucose to precursor polysac-
charides in the last step of Lewis antigen biosynthesis, to generate
fucosylated carbohydrate structures such as SSEA1. SSEA1 is reported
to play a role in cell adhesion and regulation of cell differentiation
(Eggens et al., 1989, Kojima et al., 1994). Interrogation of the micro-
array data provides validation of our data in independent external
datasets, demonstrating differential expression of several FUTs in the
human endometrium. Of particular interest, was the observation that
in women with endometriosis, SSEA1+ epithelial cells had signiﬁcantly
elevated levels of FUT4 compared with SSEA1+ epithelial cells from
healthy women without endometriosis. Cells expressing the Lewis-x
antigen (such as SSEA-1) when transfected with FUT4 adopted a more
adhesive phenotype in culture (Sudou et al., 1995). Thus, increased
FUT4 expression in SSEA1+ cells in endometrial epithelial cells from
endometriosis patients could similarly enhance their adhesive nature at
ectopic sites. This effect of FUT4 remains to be formally tested in
endometrial epithelial cells, but we anticipate gain-of-function (overex-
pression) and loss-of function (small interfering RNA) studies to
answer this in the future.
The transcription factors NANOG, OCT4, SOX2 work synergistically
at maintaining the pluripotent, embryonic stem cell phenotype
(Kashyap et al., 2009). The forced expression of these factors in som-
atic cells confers induced pluripotent stem cells status, exemplifying
their importance, and therefore they are key markers of an undifferen-
tiated state. The lack of concomitant SOX2 expression with NANOG
and OCT4 in the healthy endometrial samples and isolated cells suggest
that the adult healthy human endometrium may not contain pluripo-
tent cells. We observed a higher NANOG and OCT4 mRNA levels in
the SSEA1+ cell fraction isolated from women with endometriosis,
possibly suggesting that they are at an earlier stage of differentiation
than those from women without endometriosis. It is tempting to pos-
tulate that such differences may further contribute to the ability of
those cells in establishing an active endometriotic lesion after retro-
grade menstruation. This is corroborated by our subsequent experi-
ment where all SSEA1+ sorted cell samples from women with
endometriosis (n = 8) produced gland-like structures in 3D culture
compared to the routine success of <70% in 3D cultures of singly dis-
persed SSEA1+ cells from healthy women without endometriosis (n >
20). However, we did not test this hypothesis formally therefore fur-
ther studies are needed to conﬁrm this observation.
The ectopic lesion-like structures grown in 3D, contained cells
expressing all steroid receptors except AR. ERβ in particular, a recep-
tor that is expressed by epithelial cells throughout the cycle as well as
in hypo-oestrogenic postmenopausal endometrium, was highly
Figure 6 Schematic illustration of the possible involvement of
SSEA1+SOX9+ basalis-like cells (blue) in endometriotic ectopic
lesion formation. In women with endometriosis, functionalis
layer containing increased basalis-like SSEA1+nSOX9+ (blue)
cells will be shed at menstruation. Retrograde ﬂow of these into the
peritoneal cavity likely give rise to ectopic lesions and we have demon-
strated the ectopic lesions to contain SSEA1+nSOX9+ epithelial cells.
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expressed by the cells forming these gland-like structures (Hapangama
et al., 2015; Kamal et al., 2016). ERβ is a major player in ectopic endo-
metriotic lesion growth in many human and animal models (reviewed
in Hapangama et al., 2015; Simmen and Kelley, 2016) in agreement
with our data.
The ability of singly dispersed SSEA1+ cells derived from eutopic
endometrium to develop gland-like structures expressing a similar
panel of markers to endometriotic lesions excised from women sug-
gest a capability to generate these lesions in an ectopic environment
in vivo. SSEA1+ cells were unable to differentiate into the two meso-
dermal lineages tested in vitro while assay success was conﬁrmed in the
control hMSCs. In contrast, endometrial stromal progenitors differen-
tiate into adiopogenic, myogenic and osteogenic lineages (Schwab and
Gargett, 2007). Previous heterotopic tissue reconstitution studies
have also shown that adult endometrial epithelial cells are able to
maintain the endometrial phenotype and morphogenesis, despite the
origin of the mesenchymal stroma supporting the growth (Kurita et al.,
2001) suggesting that ectopic lesions retain the endometrial phenotype
due to the unipotent epithelial progenitor cells that likely initiate them.
Interestingly, a recent study analysing the presence of selection-neutral
passenger mutations also suggested that epithelium in the endometrio-
tic lesions was clonal and epithelial development is independent of the
stroma (Noe et al., 2018). It is however expected that the endometrial
perivascular mesenchymal stem cells would facilitate the development
of a vascular stroma also supporting the growth of endometriosis
lesions (Cousins et al., 2018; Tempest et al., 2018).
Our data is of importance for many reasons; they provide further
evidence for the involvement of basalis-like endometrial cells in the
pathogenesis of endometriosis (Fig. 6); and they add to the existing
data on endometriosis-associated eutopic endometrial aberrations.
Our study, for the ﬁrst time, provides an explanation of why 6–10% of
women develop endometriosis when almost all undergo retrograde
menstruation from a stem/progenitor cell perspective. Our data col-
lectively suggest that shedding and retrograde menstruation of basalis-
like cells is a prerequisite for ectopic lesion formation. In the context
of endometrial epithelial progenitor/stem cells, it will be important in
future studies to determine if the other suggested epithelial progenitor
cells expressing N-cadherin (Nguyen et al., 2017), or LGR5 (Tempest
et al., 2018) play a role in the pathogenesis of endometriosis. Such
studies will increase our current knowledge on the role of endometrial
basalis epithelial stem/progenitor cells in endometrial proliferative dis-
orders with potential to identify abnormalities in these basalis cell types
and exploit them for diagnostic and therapeutic strategies in endomet-
riosis as well as in other persistent endometrial proliferative disorders
with a stem/progenitor cell basis.
Supplementary data
Supplementary data are available at Human Reproduction online.
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SUPPLEMENTARY DATA
Supplementary Figure S1 Full-thickness endometrial samples from women with and without endometriosis in the secretory
phase of the cycle stained for SSEA1, SOX9 and negative control IgG by immunohistochemistry (Supplementary S1A). Scale bar
= 500 μM. Upper IgG panel shows representative goat IgG negative control staining, with representative mouse IgG negative con-
trol staining below. Higher power micrographs are presented in Fig. 1A. Representative micrographs from ectopic endometriotic lesions stained by
IHC for SSEA1 and SOX9 (Supplementary S1B). Seventeen ectopic lesions were examined from 13 women. Scale bar = 100 μm.
Supplementary Figure S2 The differential expression of (A) all FUT genes (that are altered) and SOX9 genes, and SOX9 regu-
lated genes from BaseSpace Correlation Engine software (B&C) gene set 1 (n = 237 of SOX9 regulated genes; Source Broad
Institute’s MSigDB. Genes with promoter regions [−2kb,+2 kb] around transcription start site containing the motif NNNNAACAATRGNN which
matches annotation for SOX9) and gene set 2 (n = 358 of SOX9 regulated genes; Source Broad Institute’s MSigDB. Genes with promoter regions
[−2kb,+2 kb] around transcription start site containing the motif CATTGTYY which matches annotation for SOX9) was examined in the secretory
endometrium of women with endometriosis compared with the same in women without endometriosis in all three publically available microarray data-
sets of premenopausal endometrial samples from women not on hormonal treatments (n = 35; Bioset 1=Endometrium from endometriosis patients
at mid-secretory phase vs_ normal (GSE6364, Burney et al., 2007); Bioset 2=Endometria (mid-secretory) - mildly severe endometriosis _vs_ no endo-
metriosis (GSE51981, Tamaresis et al., 2014)) and Bioset 3= Endometria (mid-secretory) – moderately severe endometriosis _vs_ no endometriosis
(GSE51981, Tamaresis et al., 2014)) using the BaseSpace Correlation Engine (BSCE; (Kupershmidt et al., 2010) software; https://www.illumina.com/
informatics/research/biological-data-interpretation/nextbio.html last accessed on August 8, 2018; Illumina, San Diego, CA, USA). BaseSpace®
Correlation Engine is a repository of over 22 000 processed and ontologically tagged omics-scale Studies from the public domain. It uses rank based
enrichment statistics to explore hypotheses and validate biomarker and signature activities based on experimental data. Gene-Bioset Correlations dis-
play Scores, which are normalised representations of gene signiﬁcance in each Bioset. Bars represent the absolute Fold Change rank of that gene in a
Bioset; Green= down-regulated, red = up-regulated. Supplementary 2A demonstrates the up-regulation of SOX9 and FUT2, FUT3, FUT4, FUT5, FUT6
and FUT7 genes and down regulation of FUT11 in these three biosets. S2B demonstrates the cumulative and detailed information on differential expres-
sion of two sets of potential SOX9 regulated genes included in BaseSpace Correlation Engine software in these three biosets suggesting a functional
relevance to the observed SOX9 upregulation. (Supplementary 2C, Supplementary 2D) Individual Bioset-Biogroup Correlation results across SOX9
binding site gene subsets 1 and 2. Each graphic shows the size of Biosets and Biogroups, a Venn Diagram of overlap and Bar Charts with the signiﬁcance
of directional subsets. Signiﬁcant down regulation of SOX9 controlled genes is evident. *Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat
CR, Lessey BA, Giudice LC. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometri-
osis. Endocrinology 2007;148:3814–3826. *Tamaresis JS, Irwin JC, Goldﬁen GA, Rabban JT, Burney RO, Nezhat C, DePaolo LV, Giudice LC. Molecular
Classiﬁcation of Endometriosis and Disease Stage Using High-Dimensional Genomic Data. Endocrinology 2014;155:4986–4999. *Kupershmidt I, Su QJ, Grewal
A, Sundaresh S, Halperin I, Flynn J, Shekar M, Wang H, Park J, Cui W et al. Ontology-based meta-analysis of global collections of high-throughput public data.
PLoS One 2010;5.: pii. e13066.
Supplementary Figure S2 Continued
Supplementary Figure S2 Continued
Supplementary Figure S3 Micrographs showing positive nuclear SOX2 expression in endometrial cancer, but no positive
staining was observed in the full thickness healthy endometrium. Representative micrographs of postmenopausal endometrium and prolif-
erative phase basalis endometrium shown. Agarose gel conﬁrmation of molecular size for PCR amplicons, positive and negative control samples and
SSEA1+ sorted cells.
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Supplementary Table SI Demographic data.
Subject Cycle stage Smoker* Endometriosis stage Parity Age (y) BMI (kg/m2) FT/pipelle
1 Menstrual 0 3–4 0 41 24.2 FT
2 Menstrual 1 2 3 42 22.4 FT
3 Proliferative 0 4 0 39 24.8 pipelle
4 Proliferative 0 2–3 0 38 28 pipelle
5 Proliferative 0 2 0 23 25.5 pipelle
6 Proliferative 0 1 1 36 29.7 pipelle
7 Proliferative 0 1 1 39 25 FT
8 Proliferative 1 2 0 45 32 FT
9 Proliferative 0 1 21 18.7 pipelle
10 Proliferative 0 1 2 41 26.6 pipelle
11 Proliferative 0 1 2 45 27.2 FT
12 Proliferative 0 2 0 31 27 pipelle
13 Secretory 0 4 0 31 20.5 pipelle
14 Secretory 1 1 2 48 22.9 FT
15 Secretory 0 2 0 46 23.9 pipelle
16 Secretory 0 2 0 43 28.4 pipelle
17 Secretory 1 4 0 27 20.6 pipelle
18 Secretory 1 1 0 28 25.5 pipelle
19 Secretory 0 3–4 1 31 28.3 pipelle
20 Secretory 0 3 0 24 pipelle
21 Secretory 0 4 0 46 FT
22 Secretory 0 1 0 38 25.2 pipelle
23 Secretory 0 4 1 39 29.6 FT
24 Secretory 0 4 2 31 26.8 pipelle
25 Secretory 0 2 2 45 20.5 FT
26 Secretory 0 2 2 30 23.8 FT
27 Secretory 0 1 2 33 20.3 FT
28 Secretory 0 1 0 38 23.3 FT
29 Secretory 1 4 1 34 28 FT
30 Secretory 0 2 4 45 29.5 FT
31 Secretory 1 1 3 44 34.9 FT
32 Secretory 0 4 0 48 29.2 FT
33 Secretory 1 1–2 2 41 27.8 pipelle
34 Secretory 1 4 1 37 37.8 pipelle
35 Secretory 0 4 2 27 pipelle
36 Secretory 0 1 0 24 18.4 pipelle
37 Secretory 0 1 0 39 22.8 pipelle
38 Secretory 1 3 0 34 18.9 pipelle
39 Secretory 0 4 1 31 40.6 pipelle
40 Secretory 0 2.5 0 25 17.1 pipelle
41 Secretory 0 4 0 34 35 pipelle
42 Secretory 1 3 1 43 26.2 FT
43 Secretory 1 1 0 29 20.6 pipelle
44 Secretory 0 1 34 26.3 pipelle
45 Menstrual 0 0 3 45 36.4 FT
46 Menstrual 0 0 2 32 26.6 FT
47 Menstrual 0 0 2 38 26.6 pipelle
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Supplementary Table SI Continued
Subject Cycle stage Smoker* Endometriosis stage Parity Age (y) BMI (kg/m2) FT/pipelle
48 Proliferative 0 0 3 41 24.7 FT
49 Proliferative 1 0 2 45 34.6 FT
50 Proliferative 1 0 2 41 22.6 FT
51 Proliferative 0 0 0 30 25 pipelle
52 Proliferative 1 0 2 32 27.8 FT
53 Proliferative 0 0 3 31 39.8 pipelle
54 Proliferative 0 0 2 42 29.8 pipelle
55 Proliferative 0 0 3 43 40.5 FT
56 Proliferative 0 0 2 45 33.1 FT
57 Proliferative 0 0 1 32 52.2 FT
58 Proliferative 0 0 1 47 23.4 FT
59 Proliferative 0 0 3 46 23.1 FT
60 Proliferative 0 0 2 47 21.6 FT
61 Proliferative 0 0 2 44 38 FT
62 Proliferative 0 0 2 44 31.6 FT
63 Proliferative 0 0 2 37 39.2 FT
64 Proliferative 0 0 1 44 29.6 FT
65 Proliferative 0 0 3 50 26.3 FT
66 Proliferative 1 0 4 47 27.7 FT
67 Proliferative 0 0 1 30 26.7 FT
68 Proliferative 0 0 2 44 24.5 pipelle
69 Proliferative 0 0 1 46 25.4 FT
70 Secretory 0 0 4 41 33.4 FT
71 Secretory 0 0 5 27 23 pipelle
72 Secretory 0 0 2 40 32.4 pipelle
73 Secretory 0 0 3 43 35.2 pipelle
74 Secretory 0 0 4 37 31.6 pipelle
75 Secretory 1 0 2 45 27.4 pipelle
76 Secretory 0 0 3 38 28.1 pipelle
77 Secretory 0 0 5 46 26.8 FT
78 Secretory 1 0 2 46 27.4 FT
79 Secretory 0 0 3 31 24.9 FT
80 Secretory 0 0 2 37 22.7 FT
81 Secretory 1 0 4 41 26.7 FT
82 Secretory 0 0 2 48 37.3 pipelle
83 Secretory 1 0 4 37 21.7 FT
84 Secretory 0 0 3 37 40 FT
85 Secretory 0 0 0 47 22.6 FT
86 Secretory 0 0 45 31.6 FT
87 Secretory 1 0 0 28 24.3 pipelle
88 Secretory 0 0 3 37 41.5 FT
89 Secretory 1 0 2 41 18.9 pipelle
90 Secretory 1 0 6 39 22.4 pipelle
91 Secretory 0 0 2 44 21 pipelle
92 Secretory 0 0 3 30 28.1 FT
93 Secretory 0 0 0 21 25.9 pipelle
94 Secretory 1 0 4 45 21.7 FT
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Supplementary Table SI Continued
Subject Cycle stage Smoker* Endometriosis stage Parity Age (y) BMI (kg/m2) FT/pipelle
95 Secretory 1 0 2 44 24.3 FT
96 Secretory 1 0 4 39 22.6 FT
97 Secretory 0 0 3 47 19.7 pipelle
98 Secretory 1 0 2 37 26.5 FT
99 Secretory 0 0 4 27 21.1 pipelle
100 Secretory 0 0 2 49 28.4 FT
101 Secretory 0 0 1 45 29.3 FT
102 Secretory 0 0 2 42 30.3 FT
*0 =No 1 = Yes.
FT = full thickness hysterectomy endometrial sample.
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Supplementary Table SII Antibody details.
Target Host species Clone Antigen retrieval
conditions
Dilution Incubation time &
temperature
Supplier
SSEA1 Mouse MC-480 Tris-EDTA pH 9.0 1:800 4°C overnight Biolegend, London, UK
SOX2 Rabbit D6D9 Citrate pH 6.0 1:50 4°C overnight Cell Signalling Technology, Herts, UK
SOX9 Goat N/A Citrate pH 6.0 1:400 4°C overnight Cell Signalling Technology, Herts, UK
Ki67 Mouse MM1 Citrate pH 6.0 1:200 4°C overnight Leica (Novocastra) Newcastle, UK
ERα Rabbit N/A Citrate pH 6.0 1:50 Room temperature, 2 h Abcam, Cambridge, UK
ERβ Mouse PPG5/10 Citrate pH 6.0 1:50 4°C overnight Biorad (AbD Serotec) Kidlington, UK
PR Mouse PgR636 Citrate pH 6.0 1:1000 Room temperature,
30 min
DAKO (Agilent), Stockport, UK
Laminin Rabbit N/A Proteinase K 1:800 4°C overnight DAKO (Agilent), Stockport, UK
Cytokeratin 18 Mouse DC10 Citrate pH 6.0 1:800 4°C overnight DAKO (Agilent), Stockport, UK
β-catenin Rabbit 6B3 Citrate pH 6.0 1:200 4°C overnight Cell Signalling Technology, Herts, UK
AR Mouse AF-441 Citrate pH 6.0 1:75 4°C overnight DAKO (Agilent), Stockport, UK
MUC-1 Mouse BC2 Citrate pH 6.0 1:100 4°C overnight Biorad (AbD Serotec) Kidlington, UK
References
Henderson TA, Saunders PT, Moffett-King A, Groome NP,
Critchley HO. Steroid receptor expression in uterine natural killer
cells. The Journal of Clinical Endocrinology and Metabolism
2003;88:440–449.
Higai K, Ishihara S, Matsumoto K. NFkappaB-p65 dependent
transcriptional regulation of glycosyltransferases in human colon
adenocarcinoma HT-29 by stimulation with tumour necrosis fac-
tor alpha. Biological & Pharmaceutical Bulletin 2006;29:2372–2377.
Marullo M, Zuccato C, Mariotti C, Lahiri N, Tabrizi SJ, Di Donato S,
Cattaneo E. Expressed Alu repeats as a novel, reliable tool for
normalisation of real-time quantitative RT-PCR data. Genome Biol
2010;11.
Masuda H, Matsuzaki Y, Hiratsu E, Ono M, Nagashima T, Kajitani T,
Arase T, Oda H, Uchida H, Asada H et al. Stem cell-like properties
of the endometrial side population: implication in endometrial
regeneration. PLoS One 2010;5: e10387.
Ponnampalam AP, Gargett CE, Rogers PA. Identiﬁcation and hormonal
regulation of a novel form of NKp30 in human endometrial epithe-
lium. Eur J Immunol 2008;38:216–226.
Wong OG, Huo Z, Siu MK, Zhang H, Jiang L, Wong ES, Cheung AN.
Hypermethylation of SOX2 Promoter in Endometrial Carcinogenesis.
Obstet Gynecol Int 2010;2010.
.............................................................................................................................................................................................
Supplementary Table SIII Primers used for qPCR.
Gene qPCR primer sequence Product Size (bp) Annealing Temperature (°C) Source
OCT4 F: 5′AGAACCGAGTGAGAGGCAA3′
R: 5′CTCTCGTTGTGCATAGTCGC3′
176 56 In house
NANOG F: 5′CGGAGACTGTCTCTCCTCTT3′
R: 5′GTTCTTGCATCTGCTGGAGG3′
240 56 In house
SOX2 F: 5′CGAGATAAACATGGCAATCAAAAT3′
R: 5′AATTCAGCAAGAAGCCTCTCCTT3′
85 56 (Wong et al., 2010)
PODXL F: 5′CCATCGTCTGCATGGCATCA3′
R: 5′CTGTCTGCAGCTCCTCTGTT3′
114 56 In house
CD133 F: 5′TGCAACAGCATCAGATTGTC3′
R: 5′TACCTGCTACGACAGTCGTG3′
199 56 In house
CD9 F: 5′GACACCTACAACAAGCTGAA3′
R: 5′ACAGGACTTCACGGTGAAGG3′
165 56 In house
ERα F: 5′TGATTGGTCTCGTCTGGCG3′
R: 5′CATGCCCTCTACACATTTTCCC3′
101 56 (Henderson et al., 2003)
PR F: 5′CAGTGGGCGTTCCAAATGA3′
R: 5′TGGTGGAATCAACTGTATGTCTTGA3′
83 56 (Henderson et al., 2003)
FUT4 F: 5′CAGCTGGTTCGAGCGGTGAAGCCGCGCT3′
R: 5′CAGAAAAACGTGAATCGGGAACAGTTGTGT3′
435 60 (Ponnampalam et al., 2008)
FUT3 F: 5′GCCGACCGCAAGGTGTAC3′
R: 5′TGACTTAGGGTTGGACATGATATCC3′
75 60 (Higai et al., 2006)
SOX9 F: 5′ GTACCCGCACTTGCACAAC 3′
R: 5′ TCTCGCTCTCGTTCAGAAGTC 3′
74 61 (Masuda et al., 2010)
YWHAZ F: 5′CGTTACTTGGCTGAGGTTGCC3′
R: 5′GTATGCTTGTTGTGACTGATCGAC3′
69 56 (Marullo et al., 2010)
